Treatment of Relapsed or Chemotherapy Refractory Chronic Lymphocytic Leukemia or Indolent B Cell Lymphoma Using Autologous T Cells Genetically Targeted to the B Cell Specific Antigen CD19
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
First Affiliated Hospital of Zhejiang University
Georgetown University
H. Lee Moffitt Cancer Center and Research Institute
Memorial Sloan Kettering Cancer Center
Assistance Publique - Hôpitaux de Paris
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Dana-Farber Cancer Institute
City of Hope Medical Center
Seattle Children's Hospital
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
St. Jude Children's Research Hospital
Beth Israel Deaconess Medical Center
M.D. Anderson Cancer Center
University of Pennsylvania
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Dana-Farber Cancer Institute
Centre Antoine Lacassagne
Seattle Children's Hospital
St. Jude Children's Research Hospital
Memorial Sloan Kettering Cancer Center
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
Children's Hospital of Philadelphia
UNC Lineberger Comprehensive Cancer Center
Dana-Farber Cancer Institute
Baylor College of Medicine
Massachusetts General Hospital
University College, London
Stanford University
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Memorial Sloan Kettering Cancer Center
University of Colorado, Denver
Dana-Farber Cancer Institute
Seattle Children's Hospital
Seattle Children's Hospital
Memorial Sloan Kettering Cancer Center
University of Pennsylvania
Seattle Children's Hospital
Seattle Children's Hospital
Montreal Heart Institute
Rigshospitalet, Denmark
City of Hope Medical Center
City of Hope Medical Center
Peking University First Hospital
Memorial Sloan Kettering Cancer Center